Učitavanje...

Comparison of health technology assessment for new medicines in France and England: an example based on ixazomib for patients with relapsed or refractory multiple myeloma

Introduction: The appraisal of medicines is often a complex and iterative process. We compared the health technology assessment (HTA) process in England and France taking as a case study the example of ixazomib for multiple myeloma. Methods: We undertook an analysis of eight relevant published docum...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Xavier Armoiry, Hans-Martin Spath, Aileen Clarke, Martin Connock, Paul Sutcliffe, Claude Dussart
Format: Artigo
Jezik:Inglês
Izdano: Taylor & Francis Group 2019-01-01
Serija:Journal of Market Access & Health Policy
Teme:
has
Online pristup:http://dx.doi.org/10.1080/20016689.2019.1648971
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!